| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-12 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-11 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-11 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-10 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-10 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-10 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-10 |
| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-09 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |